NCT07307885

Brief Summary

Photobiomodulation Group (Intervention Group): Before the intervention, the patient's skin sensitivity to light will be tested by applying light for 3 minutes to one-fourth of the forearm skin. If redness occurs and persists for more than 2 hours, this indicates photosensitivity, and the intervention will not be performed. The Patient Information Form will be completed during the first meeting with the patients included in the study. Subsequently, blood values will be determined, the Patient Assessment Form will be filled out, vital signs will be measured, and then the intervention will begin. After routine wound care/cleaning procedures in the intensive care unit, without applying any medication, cream, or lotion to the wound area, red light (660 nm wavelength) will be applied to the wound area for 5 minutes at a distance of 55 cm during the first 3 days, and for 10 minutes at the same distance on the following days. This application will continue once daily for 14 days. Wound assessments will be performed, and photographs will be taken on Day 1, Day 4, Day 7, and Day 14 (Baracho et al., 2021; Viecelli et al., 2024; Lima et al., 2020). Control Group: The Patient Information Form will be completed during the first meeting with the patients included in the study. Subsequently, blood values will be determined, the Patient Assessment Form will be filled out, and vital signs will be measured. No intervention will be performed other than the routine wound care procedure carried out in the intensive care unit. Wound assessments will be performed, and photographs will be taken on Day 1, Day 4, Day 7, and Day 14, in the same manner as in the intervention group.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
13mo left

Started May 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
May 2026May 2027

First Submitted

Initial submission to the registry

December 8, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

December 29, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2027

Last Updated

March 9, 2026

Status Verified

March 1, 2026

Enrollment Period

11 months

First QC Date

December 8, 2025

Last Update Submit

March 6, 2026

Conditions

Keywords

photobiomodulationPressure Ulcerwound care

Outcome Measures

Primary Outcomes (1)

  • The healing of pressure sores in the patients in the experimental group will be faster and more effective than in the control group.

    This application will be continued once a day for 14 days and wound evaluation will be made and wound photographs will be taken on days 1, 4, 7 and 14. Wound assessment will be based on Pressure Ulcer Scale for Healing-PUSH and wound measurement(diameter).

    14 days

Study Arms (2)

photobiomodulation group

EXPERIMENTAL

photobiomodulation intervention group

Device: photobiomodulation

control group

NO INTERVENTION

routine hospital care

Interventions

The effectiveness of photobiomodulation application in chronic wound healing will be evaluated.

photobiomodulation group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Stage II pressure ulcers
  • Patients without any skin disease
  • Patients with albumin, platelet, and blood glucose levels within normal ranges
  • Patients who will stay in the intensive care unit for 14 days or longer
  • Patients with a BMI of 35 or below
  • Patients with vital signs within normal limits
  • Patients with an oxygen saturation level of 90% or above

You may not qualify if:

  • Patients who do not consent to participate in the study
  • Patients with severe nutritional problems and those who are cachectic
  • Patients with severe edema (+4 or above)
  • Patients with diabetes mellitus
  • Patients who show photosensitivity in the light sensitivity test
  • Patients with metastatic tumors, high fever, thromboangiitis obliterans, vascular insufficiency, active tuberculosis, acute soft tissue infection, pregnancy, bleeding tendency, skin sensory disorders, or skin allergies
  • Patients with acute injuries within the past 72 hours
  • Patients with a pacemaker, defibrillator, or other electronic implants
  • Patients taking medications known to cause photosensitivity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pressure Ulcer

Interventions

Low-Level Light Therapy

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Laser TherapyTherapeuticsPhototherapy

Central Study Contacts

Hülya Elmalı Şimşek, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Asst Prof

Study Record Dates

First Submitted

December 8, 2025

First Posted

December 29, 2025

Study Start

May 1, 2026

Primary Completion (Estimated)

March 20, 2027

Study Completion (Estimated)

May 20, 2027

Last Updated

March 9, 2026

Record last verified: 2026-03